Plain-English translation of NCT07679074 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The CREST study is testing a guided care program called the Samphire Guided Care Program for people with menstrual or pelvic health symptoms like premenstrual syndrome, endometriosis, or menopause-related mood and cognitive problems. The program includes an initial assessment by a women's health clinician, an optional at-home device called Lutea that uses gentle electrical brain stimulation, ongoing coaching support, and an app to track your symptoms. Researchers want to see whether this combination helps improve your mood, reduce brain fog, and help you work and feel better overall.
Many people with menstrual and pelvic health conditions struggle with mood changes, difficulty concentrating, and fatigue that interfere with work and daily life. This trial is testing whether adding guided support and optional brain stimulation can provide real relief and help people feel and function better.
You likely qualify if…
You likely don't qualify if…
Over 12 weeks, you will complete an initial online assessment with a women's health clinician to see if you're eligible for the optional brain stimulation device. All activities happen at home through a mobile app and online platform. If you choose to use the Lutea device, you would use it for short sessions as recommended. Throughout the study, you'll track your symptoms in the app and complete questionnaires about your mood, work productivity, and quality of life at the start, middle, and end of the program. You'll also have support from a Samphire health coach via the app.
AI-generated summary from trial data · Aug 27, 2026 · Not medical advice
United States